Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Contura International A/S
Description97.5% water and 2.5% cross-linked polyacrylamide hydrogel optimized for urethral bulking
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationIncontinence
Indication DetailsTreat stress urinary incontinence (SUI)
Regulatory Designation
PartnerJohnson & Johnson

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today